Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Clinical trial NCT00089284 · TERMINATED

Trial details

NCT number: NCT00089284
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (NHL)

Start date: 2003-10-28
Primary completion: 2007-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.